Ripudaman Singh

Ripudaman Singh serves as Chief Technology Officer at ARCEDI Biotech. ARCEDI Biotech operates in the research sector with approximately 26.0 employees. The company is headquartered in Aarhus.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • Our database includes 201,464 c suite-level executives.

Outlook Microsoft Office 365 Google Cloud Hosting AI

rare cell detection circulating fetal cells innovation biotechnology prenatal diagnosis noninvasive prenatal testing biotechnology research non-invasive prenatal testing nipt cell-based prenatal diagnosis fetal cell isolation genomic analysis evita test evita test complete evita test gender chromosomal analysis sub-chromosomal analysis cystic fibrosis testing maternal blood samples prenatal diagnostics genome-wide analysis fish analysis microdeletions detection microduplications detection chromosomal aberrations detection dna analysis gender determination genetic status detection clinical geneticist review automated cell sorting fluorescence activated cell sorting preimplantation genetic testing chrionic villus sampling alternatives amniocentesis alternatives prenatal genetic testing fetal aneuploidy screening monogenic disorders screening timely results safe prenatal screening comprehensive testing screening for trisomies detection of pathogenic conditions molecular testing obstetric collaboration non-invasive diagnostic methods innovative medical technology rare cell diagnostics high-throughput process regulatory compliance patented technology medical research fetal dna analysis patient care improvements clinical implementation family planning testing

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Ripudaman Singh in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at ARCEDI Biotech.

Ripudaman Singh's Position in the MessageCEO Database

• •Ripudaman Singh is 1 of 1 verified executive contact we track at ARCEDI Biotech.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •36 verified contacts work at research companies in the 26.0 employee range (same size as ARCEDI Biotech).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

How do I reach Ripudaman Singh directly?

Ripudaman Singh's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at ARCEDI Biotech. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Ripudaman Singh work for?

Ripudaman Singh is Chief Technology Officer at ARCEDI Biotech, a company in the research sector with 26.0 employees. The company is based in Aarhus.

Can I pitch or sell to Ripudaman Singh?

As Chief Technology Officer at ARCEDI Biotech, Ripudaman Singh is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Ripudaman Singh directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Ripudaman Singh in?

Ripudaman Singh works in the research industry as Chief Technology Officer at ARCEDI Biotech. MessageCEO provides verified contact information for executives across all major industries.

Is Ripudaman Singh's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Ripudaman Singh's profile is kept up-to-date with the latest available information.

Last updated: November 5, 2026